Medisafe®

Scaling patient engagement introduces more than complexity. It introduces responsibility. As programs grow, organizations need confidence that the technology supporting patients is secure, reliable, and built to meet the demands of healthcare. That's why Medisafe was built with enterprise-grade infrastructure and globally recognized security and compliance standards at its core. Trust isn't something you add later. It's something you build from the start. Learn more at Medisafe.com

What if persistence could be predicted? Medisafe's analysis of millions of managed doses and more than 12 years of adherence data has uncovered behavioral signals that help identify adherence risk before patients disengage. The findings highlight why patient support programs must monitor more than dose completion to identify patients at risk of disengagement. Explore the behavioral patterns shaping metabolic therapy persistence and the opportunities they create for pharmaceutical organizations. https://lnkd.in/gupa-2Tf

Our CTO, Rotem Shor, shares his POV on how patient engagement has evolved over the years. Do you agree that the ultimate goal should be to create connected experiences that meet people where they are, when and how they choose to engage? Here at Medisafe, we believe the next generation of successful patient programs will be defined by their ability to adapt to the individual.

Educate. Motivate. Personalize. Adapt. That's what separates patient engagement from patient outreach. The Medisafe Digital Companion combines personalized education, behavioral science, and intelligent support to help patients stay engaged throughout their treatment journey. The result is a patient experience designed to drive lasting participation. See what's powering long-term patient engagement. https://lnkd.in/ebwB5ArT

An informed patient is an engaged patient. Medication reminders matter. But lasting engagement comes from helping patients understand their condition, treatment, and the role they play in their own health. That's why Medisafe delivers personalized, condition-specific education throughout the patient journey, providing relevant content and support when patients need it most. Learn how Medisafe helps patients stay engaged beyond the reminder. https://lnkd.in/e__xeeEd

What if technology could make patients feel more supported, not just more connected? That's the idea behind Medisafe's Digital Companion. By combining behavioral science and intelligent engagement, it creates an experience patients trust and rely on. IQVIA research shows that digital engagement can have a meaningful impact on therapy persistence. See what the data reveals about the connection between digital engagement and therapy persistence. https://lnkd.in/eX_ihpw5

Breast cancer treatment is evolving, but adherence remains a critical gap. Evidence indicates that up to 40–50% of patients discontinue or skip doses of oral therapies within the first year, increasing recurrence risk by up to 50%. Medisafe real-world insights show that while most patients feel more in control with digital support and value timely reminders, everyday forgetfulness and side effects continue to drive non-adherence. The data are clear: sustaining therapy is as much a behavioral challenge as a clinical one. Medisafe helps close that gap with real-time engagement that supports patients through the moments that make a difference. Because in oncology, every dose matters. Read more- https://lnkd.in/ejUevei7

Pharma brand teams often write off chronically non-adherent patient populations as unreachable. Real-world claims data prove otherwise. A retrospective cohort study of 4,000+ users evaluates exactly what happens when you introduce predictive behavioral science: +8 percentage point increase in average Medication Possession Ratio (MPR) 71% → 86% of patients achieving “good adherence” (MPR ≥ 0.8) 74% of low-adherence users (<50% MPR) improved by up to 5 deciles Across a high-risk, often asymptomatic population, Medisafe helped move patients from inconsistent medication use to sustained adherence patterns. Real-world behavior change with measurable clinical impact. Read more: https://lnkd.in/eKTAX4sz

Reminding a patient to take a medication doesn't work if the digital tool is too complex to navigate. A recent clinical trial evaluated Medisafe's digital companion across vulnerable patient populations at a U.S. Federally Qualified Health Center (FQHC). The data highlights exactly what happens when you eliminate user friction: → 93% Adherence Success: Patients confirmed the app kept them on time. → 93% Adoption Rate: Users verified the interface was simple and seamless. → 100% Net Advocacy: Every single participant would recommend the app. True treatment retention comes from deploying an accessible, behavior-driven companion that patients actually want to use. Read more: https://lnkd.in/eXDvvXxK

Reminding a patient to take a medication doesn't work if you don't understand why they are skipping a dose. 55% of non-adherence is tied directly to communication gaps and the mental friction of managing complex therapy schedules. The challenge isn’t just reminding patients to take medication. It’s understanding the factors of why they disengage in the first place. That’s why Medisafe uses real-world, therapy-specific behavioral signals to identify risk early and deliver support at the right moment—helping patients navigate their treatment journey and stay connected throughout therapy. Because better adherence starts with understanding patient behavior, not just tracking refills. Read more: https://lnkd.in/eHr8fKeP